Validation and cross-cultural adaptation of the depression Patient’s Health Questionnaire – 9 in the Romanian population of patients with Type 2 Diabetes Mellitus
Authors Lupascu N, Timar B, Albai A, Roman D, Potre O, Timar R
Received 27 January 2019
Accepted for publication 9 April 2019
Published 30 May 2019 Volume 2019:12 Pages 841—849
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Ms Justinn Cochran
Peer reviewer comments 3
Editor who approved publication: Dr Antonio Brunetti
Nicoleta Lupascu,1 Bogdan Timar,2,3 Alin Albai,1,3 Deiana Roman,1 Ovidiu Potre,4,5 Romulus Timar1,3
1Second Department of Internal Medicine, “Victor Babes” University of Medicine and Pharmacy, Timisoara, Romania; 2Department of Functional Sciences, “Victor Babes” University of Medicine and Pharmacy, Timisoara, Romania; 3Department of Diabetes and Metabolic Diseases, “Pius Brinzeu” Emergency Hospital, Timisoara, Romania; 4First Department of Internal Medicine, “Victor Babes” University of Medicine and Pharmacy, Timisoara, Romania; 5Department of Hematology, Municipal Emergency Hospital, Timisoara, Romania
Purpose: To validate and to evaluate the performance in depression screening of the Patient’s Health Questionnaire – 9 (PHQ-9) for Romanian patients with Type 2 Diabetes Mellitus (T2DM).
Patients and methods: In a consecutive-case, population-based, non-interventional study design 107 hospitalized patients with T2DM were enrolled. The PHQ-9 was evaluated in regard to its acceptability, ceiling and floor effect, reproducibility, and test–retest performance. Its validity was tested by comparing it to the Beck depression scale, which is a validated tool for this patient population.
Results: The PHQ-9 questionnaire had an excellent acceptability, having no non-responders for any of its questions and a median completion time of 3 mins and 12 s, a good reliability with a Cronbach’s α=0.897 [0.865–0.924] 95%CI, a good test–retest performance (Spearman’s rho =0.972; p<0.001 between two administrations of the test) without any ceiling or floor effect observed for the total score. At the same time, the score demonstrated a good validity when compared to a more complex and previously validated instrument like the Beck depression scale (Spearman’s rho =0.777; p<0.001). The limits of agreement (Bland-Altmann analysis) between the two measurements are 2.6 to −2.5 points.
Conclusion: The PHQ-9 is a valid, useful instrument for depression screening in Romanian patients with T2DM.
Keywords: questionnaire validation, depression screening, chronic diseases, screening instrument, depression in diabetes
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]